Summary Comments
- Most frequently detected viruses in October (all age groups):
- Rhino/Enterovirus: 27%
- Rhinovirus: 20.5%
- SARS-CoV-2: 14.65%
- Parainfluenza 1–4: 12.2%
- Epidemiological Week 1–43:
- SARS-CoV-2: Stable over past 4 weeks; 14.5% positivity in week 43
- RSV A & B: Low; 2.4% positivity in week 43
- Influenza A: 1.3% positivity in week 43
- Influenza B: Increased from 2.4% (week 39) to 5.8% (week 43)
Respiratory Viral Multiplex PCR and SARS-CoV-2 PCR: All Age Groups
September 2023:
- Rhino/Enterovirus: 29.3%
- Rhinovirus: 24.8%
- SARS-CoV-2: 13%
- Parainfluenza 1–4: 12.4%
- Adenovirus: 5.9%
- Influenza A: 3.2%
- Influenza B: 5.7%
- RSV: 2.6%
- Human metapneumovirus: 8.8%
October 2023:
- Rhino/Enterovirus: 27%
- Rhinovirus: 20.5%
- SARS-CoV-2: 14.65%
- Parainfluenza 1–4: 12.2%
- Adenovirus: 6.5%
- Influenza A: 3.7%
- Influenza B: 4.4%
- RSV: 1.9%
- Human metapneumovirus: 7.6%
Atypical Bacterial Pathogens (Weeks 1–43)
Total Cases:
- B. pertussis: 537
- 0–6 months: 25%
- 6–12 years: 22%
- 1–5 years: 19% 18 years: 23%
- M. pneumoniae: 1,518
- Peak: week 25 (72 cases)
- 1–5 years: 38%
- 6–12 years: 28%
Paediatric Respiratory Viral Multiplex PCR Data (Ages 0–12)
<1 Year Age Group
September 2023:
- Rhino/Enterovirus: 39%
- Rhinovirus: 30.2%
- Parainfluenza 1–4: 19.1%
- Adenovirus: 11.3%
- SARS-CoV-2: 11.3%
- RSV: 6.2%
- Influenza A: 4.4%
- Influenza B: 6.2%
- Enterovirus: 4.8%
October 2023:
- Rhino/Enterovirus: 35.8%
- Rhinovirus: 28.7%
- Parainfluenza 1–4: 19%
- Adenovirus: 11.3%
- SARS-CoV-2: 9.3%
- RSV: 5.2%
- Influenza A: 4.2%
- Influenza B: 0.4%
- Enterovirus: 6.1%
1–5 Year Age Group
September 2023:
- Rhino/Enterovirus: 46.3%
- Rhinovirus: 38.6%
- Parainfluenza 1–4: 18.3%
- Enterovirus: 15.6%
- Adenovirus: 14.8%
- SARS-CoV-2: 17.1%
- Influenza A: 6.4%
- Influenza B: 6.3%
- RSV: 3.5%
October 2023:
- Rhino/Enterovirus: 47.3%
- Rhinovirus: 32.7%
- Parainfluenza 1–4: 19%
- Enterovirus: 15.6%
- Adenovirus: 14.8%
- SARS-CoV-2: 14.5%
- Influenza A: 6.3%
- Influenza B: 0.9%
- RSV: 3.6%
6–12 Year Age Group
September 2023:
- Rhino/Enterovirus: 29.4%
- Rhinovirus: 33.5%
- Influenza B: 10.5%
- SARS-CoV-2: 5.4%
- RSV: 1.4%
- Adenovirus: 6.4%
- Influenza A: 1.3%
October 2023:
- Rhino/Enterovirus: 33.2%
- Rhinovirus: 28%
- Influenza B: 10.5%
- SARS-CoV-2: 6.4%
- RSV: 0.4%
- Adenovirus: 5.6%
- Influenza A: 1.9%
Age-Specific Highlights (October 2023)
- <1 year:
- Rhino/Enterovirus (35.8%), Rhinovirus (28.7%), Parainfluenza 1–4 (19%), Adenovirus (11.3%)
- 1–5 years:
- Rhino/Enterovirus (47.3%), Rhinovirus (32.7%), Parainfluenza 1–4 (19%), Enterovirus (15.6%)
- 6–12 years:
- Rhino/Enterovirus (33.2%), Rhinovirus (28%), Influenza B (10.5%)
Continue Reading